Tekna maintains focus on plasma and powder businesses

• Tekna is posting significant growth in its order backlog, revenue and margins in 2026, CEO Claude Jean said.
• The strategy remains focused on plasma systems and powders, targeting medical, aerospace and defense markets as customers shift toward volume production.
• Customer demand is rising for higher volumes, shorter lead times and quality certification.
• Materials orders from a European medical distributor totaled CAD 1.6 million, according to an October 20 update.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arendals Fossekompani ASA published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.